Quantcast

Latest rheumatoid arthritis Stories

2014-09-18 23:03:16

Arthritis Society says patient safety paramount as new class of medications become available Toronto, ON (PRWEB) September 18, 2014 With the arrival of subsequent-entry biologics (SEBs) set to alter the arthritis treatment landscape, The Arthritis Society released new resources to educate stakeholders on their potential impact. The bottom line: safety and strong public policy must guide SEB use, and patients must be well informed when speaking to their healthcare team. Click here for an...

2014-09-17 08:31:07

-Enhances Capabilities for the Precision Medicine in Immuno-oncology and Autoimmune Disease Areas- LOS ANGELES and LEIPZIG, Germany, Sept. 17, 2014 /PRNewswire/ -- ImaginAb, Inc. today announced that it has entered into an exclusive technology development partnership with Novotectid GmbH for the development of antibody-based imaging agents to image CD4+ positive immune T cells. "Our collaboration with Novotectid expands ImaginAb's capability to precisely diagnose and determine...

2014-09-16 12:30:41

Rheumatologists Report that the Vast Majority of RA Patients Who are Candidates for Biologic Treatment Receive a Biologic, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept. 16, 2014 /PRNewswire/ -- Decision Resources Group finds that the percentage of rheumatoid arthritis (RA) patients treated with a biologic agent by rheumatologists has remained relatively constant since 2012 in the major European markets (France, Germany, Italy, Spain and the United Kingdom)....

2014-09-16 12:30:11

The Imminent Entry of Biosimilars Will Constrain Sales of Branded Biologics and Premium-Priced Emerging Agents, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept. 16, 2014 /PRNewswire/ -- Decision Resources Group finds that the rheumatoid arthritis (RA) disease-modifying antirheumatic drug market will increase from $14 billion in 2013 to over $18.2 billion in 2023 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. TNF-alpha inhibitors...

2014-09-09 23:03:08

New Arthritis Society projects include smartphone app to manage pain in kids. Toronto, Ontario (PRWEB) September 09, 2014 The Arthritis Society today announced the commitment of $3.4 million in funding for arthritis research across Canada this year. The funding will be used to fund both established researchers as well as provide young investigators with their first opportunities to explore novel ideas within the field of arthritis research. A total of 18 new projects will be funded....

2014-08-27 12:30:09

Testing for the protein 14-3-3eta may improve the diagnosis of RA, including in early stages when treatment is most likely to improve outcomes MADISON, N.J., Aug. 27, 2014 /PRNewswire/ -- A novel biomarker for rheumatoid arthritis (RA) has significant potential to help physicians better identify early-stage disease, when treatment can often arrest further disease progression and disability, according to a new study in The Journal of Rheumatology....

2014-08-20 08:27:57

Be Joint Smart to educate roughly 43,500 local residents with PsA about their disease PORTLAND, Ore., Aug. 20, 2014 /PRNewswire-USNewswire/ -- If you're one of the roughly 43,500 D.C. metro residents struggling with pain from psoriatic arthritis (PsA)--an inflammatory autoimmune disease that causes pain, swelling and stiffness of the joints and tendons--learn to control your condition with Be Joint Smart, a free psoriatic arthritis program presented by the National Psoriasis Foundation, at...

2014-08-18 12:26:55

Nearly 80 Percent of Surveyed Physicians Believe Xeljanz is Superior to Methotrexate in Inhibiting Structural Progression in RA, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug. 18, 2014 /PRNewswire/ -- Decision Resources Group finds that the FDA approval of Pfizer's supplemental New Drug Application for Xeljanz in February 2014 to include the reduction of radiographic progression of structural joint damage has had a positive impact on U.S. rheumatologists'...

2014-08-12 23:06:16

Curriculum Developed by The Arthritis Society Toronto, ON (PRWEB) August 12, 2014 Pharmacists across the country will soon receive specialized training to better support the unique health needs of those living with arthritis thanks to the launch of a new on-line education program designed by The Arthritis Society. Pharmacists who complete the training will receive certification and be able to offer a wider range of tailored consultations to their patients with arthritis. This is in...

Rubbing Hands Together
2014-08-11 04:39:09

Rayshell Clapper for redOrbit.com - Your Universe Online Arthritis is a very painful inflammation of one or more of a person’s joints. It can simply be a dull, annoying ache, but arthritis may cause severe to debilitating pain. Many people suffer from different types of arthritis. To better understand arthritis, it is important to understand the common types that are regularly diagnosed. Medline Plus, a project supported by the National Institutes of Health, shows five major common types...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.